Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Rapid Diagnostic Testing 2022 - SARS-CoV-2 & Beyond

Joanna Sickler's Biography

Joanna Sickler, Head of Healthcare Systems Policy, Roche Diagnostics

Joanna Sickler is the Head of Healthcare Systems Policy at Roche Diagnostics. She recently served as a Team Lead for the Roche Molecular Diagnostics global medical affairs team where she was responsible for developing and executing the point-of-care global medical strategy and leading clinical impact studies across the molecular infectious disease portfolio. This included a heavy emphasis on respiratory tests and focus on pandemic response to COVID-19. Prior to joining Roche at Zyomyx, she led market access strategy, policy and the post-approval clinical study program to support the launch of the Company’s first product, a point-of-care CD4 test for use in limited resource settings. Previously, as part of the Access Programs leadership team at the Clinton Health Access Initiative (CHAI), she developed models and led advocacy for global procurement interventions to ensure the sustainability of the children’s HIV drug market. She partnered with Ministries of Health throughout Africa to support the HIV Guidelines revision process and assess the cost impact of changes. She holds Masters in Public Health and Masters in Business Administration degrees from the University of California, Berkeley. She received her Bachelor of Arts degree from Wesleyan University and is currently pursuing her Doctorate in Public Health at Johns Hopkins University.

Joanna Sickler Image

One Size Does Not Fit All: COVID-19 Testing Strategies

Monday, 21 March 2022 at 16:00

Add to Calendar ▼2022-03-21 16:00:002022-03-21 17:00:00Europe/LondonOne Size Does Not Fit All: COVID-19 Testing StrategiesRapid Diagnostic Testing 2022 - SARS-CoV-2 and Beyond in

Effective implementation of diagnostic tests requires an understanding of strengths and weaknesses of each technology platform.  Molecular, antigen, point-of-care, home testing and central lab solutions are all needed to meet the challenge of the COVID-19 pandemic.  This presentation will focus on the product characteristics of the rapid point-of-care technologies that are available today, strategies for effective use in testing programs and gaps in the current testing landscape.

Add to Calendar ▼2022-03-21 00:00:002022-03-22 00:00:00Europe/LondonRapid Diagnostic Testing 2022 - SARS-CoV-2 and BeyondRapid Diagnostic Testing 2022 - SARS-CoV-2 and Beyond in